We regret to inform you that the Precision Cancer Medicine will cease publication effective May 2026, following a joint decision reached by the Fudan University Shanghai Cancer Center and our publishing house.
As of this date, the journal will be archived and will no longer accept new submissions through AME Publishing Company. All articles published in the journal during its time with us will remain fully accessible and searchable on our websites.
We extend our sincere gratitude to all the editors, reviewers, authors, and readers who have contributed to and supported the journal over the years.